We plan to invest £54.3M in a new state-of-the-art research building on the Gibbet Hill campus that will bring together up to 300 biomedical researchers from across the School of Life Sciences and Warwick Medical School to fight human diseases.
Our work in the Interdisciplinary Biomedical Research Building (IBRB) will focus on understanding the origins and mechanistic basis of diseases of the body and brain, with the aim of finding new ways to extend healthy life spans. It will build on our existing world-class research in neuroscience, microbiology and infection, cell biology, and disease models, supporting and facilitating interdisciplinary biomedical research of the highest quality.
It will provide the two Schools with a world-class environment in which to train future generations of biomedical researchers. The student experience for undergraduates and postgraduates will be enriched through the provision of a new 400-seat lecture theatre and many new social and collaboration spaces.
Professor Lorenzo Frigerio, Head of the School of Life Sciences said:
“This is a tremendous opportunity for SLS and WMS to deliver world-class biomedical science in an environment that will act as a catalyst for novel research and collaboration.”
Professor Sudhesh Kumar, Dean of the Warwick Medical School added:
“We are very excited about the development of the new IBRB building on the Gibbet Hill site. It forms an integral element of the Medical School’s ambitions over the coming years. The inclusion of a brand new lecture theatre will enhance student experience and enable growth of new undergraduate programmes. The excellent research facilities within the building will foster inter-disciplinary collaboration and enable biomedical research at the highest level.”